关注
Krishna Jadhav
标题
引用次数
引用次数
年份
Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy
K Vaghasiya, E Ray, R Singh, K Jadhav, A Sharma, R Khan, OP Katare, ...
Materials Science and Engineering: C 123, 112027, 2021
682021
Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
E Kole, K Jadhav, N Shirsath, P Dudhe, RK Verma, A Chatterjee, J Naik
Journal of Drug Delivery Science and Technology 81, 104261, 2023
182023
Fat fighting liraglutide based nano-formulation to reverse obesity: design, development and animal trials
DK Jakhar, VK Vishwakarma, R Singh, K Jadhav, S Shah, T Arora, ...
International Journal of Pharmaceutics 634, 122585, 2023
112023
Systematic development and optimization of spray-dried Quercetin-HP-β-cyclodextrin microparticles for DPI-based therapy of lung cancer
K Vaghasiya, E Ray, A Sharma, R Singh, K Jadhav, R Khan, OP Katare, ...
Journal of Materials Science 56 (26), 14700-14716, 2021
102021
Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation
K Jadhav, A Jhilta, R Singh, E Ray, N Sharma, R Shukla, AK Singh, ...
Biomaterials Advances 154, 213594, 2023
92023
Taming the devil: antimicrobial peptides for safer TB therapeutics
K Jadhav, R Singh, E Ray, AK Singh, RK Verma
Current Protein and Peptide Science 23 (10), 643-656, 2022
82022
New Generation smart drug delivery systems for Rheumatoid arthritis.
R Singh, K Jadhav, K Vaghasiya, E Ray, R Shukla, RK Verma
Current Pharmaceutical Design, 2023
62023
Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): Animal trials and study in human fibroblast …
R Singh, K Jadhav, R Kamboj, H Malhotra, E Ray, A Jhilta, V Dhir, ...
Biomaterials Advances 160, 213853, 2024
42024
Neurodegenerative disorders due to inhalation of various small particles
K Jadhav, R Singh, E Ray, K Vaghasiya, RK Verma
Nanomedical Drug Delivery for Neurodegenerative Diseases, 41-54, 2022
32022
A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals
K Jadhav, E Kole, R Singh, SK Rout, RK Verma, A Chatterjee, ...
Drying Technology, 1-27, 2024
22024
Recent Developments in Tyrosine Kinase Inhibitor-based Nanotherapeutics for EGFR-resistant Non-small Cell Lung Cancer.
E Kole, K Jadhav, R Singh, S Mandpe, A Abhang, RK Verma, J Naik
Current Drug Delivery, 2024
22024
Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression
A Jhilta, K Jadhav, R Singh, E Ray, A Kumar, AK Singh, RK Verma
ACS Infectious Diseases, 2024
12024
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
K Jadhav, R Singh, A Panghal, A Thakur, RK Verma, C Singh, M Goyal, ...
Molecular Neurobiology, 1-25, 2024
2024
Targeted delivery of metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid Nano-assemblies
E Ray, K Jadhav, M Kadian, G Sharma, K Sharma, A Jhilta, R Singh, ...
2024
Nanoparticles for Controlled Delivery of Proteins and Peptides
R Singh, K Jadhav, E Ray, K Vaghasiya, RK Verma
Nanomedicine, Nanotheranostics and Nanobiotechnology, 26, 2024
2024
Effective Cerebral Tuberculosis Treatment via Nose-to-Brain Transport of Anti-TB Drugs Using Muco-Adhesive Nano-aggregates
K Jadhav, A Jhilta, R Singh, V Kumar, A Yadav, AK Singh, RK Verma, ...
Nanoscale, 2024
2024
Therapeutic potential of nano assisted delivery in tuberculosis and its management
R Singh, K Jadhav, A Jhilta, RK Verma
Nanostructured Drug Delivery Systems in Infectious Disease Treatment, 123-143, 2024
2024
Application of nanoemulsion in pharmaceuticals industry
K Jadhav, R Singh, E Ray, RK Verma
Industrial Applications of Nanoemulsion, 107-156, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–18